nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocodone—Naloxone—TLR4—Crohn's disease	0.0468	0.889	CrCbGaD
Hydrocodone—Withdrawal syndrome—Prednisone—Crohn's disease	0.0175	0.0281	CcSEcCtD
Hydrocodone—Neck pain—Mesalazine—Crohn's disease	0.014	0.0224	CcSEcCtD
Hydrocodone—Musculoskeletal pain—Mesalazine—Crohn's disease	0.014	0.0224	CcSEcCtD
Hydrocodone—Deafness—Mesalazine—Crohn's disease	0.0112	0.018	CcSEcCtD
Hydrocodone—Malnutrition—Mercaptopurine—Crohn's disease	0.0111	0.0179	CcSEcCtD
Hydrocodone—Lethargy—Mesalazine—Crohn's disease	0.0102	0.0164	CcSEcCtD
Hydrocodone—Osteoarthritis—Mesalazine—Crohn's disease	0.01	0.0161	CcSEcCtD
Hydrocodone—Affect lability—Mesalazine—Crohn's disease	0.00989	0.0158	CcSEcCtD
Hydrocodone—Migraine—Mesalazine—Crohn's disease	0.00989	0.0158	CcSEcCtD
Hydrocodone—Mood swings—Mesalazine—Crohn's disease	0.00951	0.0152	CcSEcCtD
Hydrocodone—Arthralgia—Mercaptopurine—Crohn's disease	0.00949	0.0152	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00942	0.0151	CcSEcCtD
Hydrocodone—Abdominal discomfort—Azathioprine—Crohn's disease	0.00914	0.0146	CcSEcCtD
Hydrocodone—OPRD1—Peptide GPCRs—CCR9—Crohn's disease	0.00894	0.0277	CbGpPWpGaD
Hydrocodone—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00891	0.0143	CcSEcCtD
Hydrocodone—Skin disorder—Mercaptopurine—Crohn's disease	0.00883	0.0142	CcSEcCtD
Hydrocodone—Contusion—Prednisone—Crohn's disease	0.00839	0.0134	CcSEcCtD
Hydrocodone—Abdominal discomfort—Mesalazine—Crohn's disease	0.00832	0.0133	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00829	0.0133	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00807	0.0129	CcSEcCtD
Hydrocodone—Agranulocytosis—Azathioprine—Crohn's disease	0.00793	0.0127	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00785	0.0126	CcSEcCtD
Hydrocodone—OPRK1—Peptide GPCRs—CCR9—Crohn's disease	0.00784	0.0243	CbGpPWpGaD
Hydrocodone—Urinary tract infection—Mesalazine—Crohn's disease	0.00752	0.0121	CcSEcCtD
Hydrocodone—Agranulocytosis—Mesalazine—Crohn's disease	0.00722	0.0116	CcSEcCtD
Hydrocodone—Body temperature increased—Mercaptopurine—Crohn's disease	0.00719	0.0115	CcSEcCtD
Hydrocodone—Mediastinal disorder—Azathioprine—Crohn's disease	0.00687	0.011	CcSEcCtD
Hydrocodone—Oedema peripheral—Mesalazine—Crohn's disease	0.00684	0.011	CcSEcCtD
Hydrocodone—Connective tissue disorder—Mesalazine—Crohn's disease	0.00683	0.0109	CcSEcCtD
Hydrocodone—Hypersensitivity—Mercaptopurine—Crohn's disease	0.0067	0.0107	CcSEcCtD
Hydrocodone—OPRM1—Peptide GPCRs—CCR9—Crohn's disease	0.00663	0.0205	CbGpPWpGaD
Hydrocodone—OPRD1—Peptide ligand-binding receptors—ACKR2—Crohn's disease	0.0064	0.0198	CbGpPWpGaD
Hydrocodone—Angiopathy—Mesalazine—Crohn's disease	0.0063	0.0101	CcSEcCtD
Hydrocodone—Mediastinal disorder—Mesalazine—Crohn's disease	0.00626	0.01	CcSEcCtD
Hydrocodone—Mental disorder—Mesalazine—Crohn's disease	0.00609	0.00975	CcSEcCtD
Hydrocodone—OPRD1—Peptide ligand-binding receptors—MLN—Crohn's disease	0.00607	0.0188	CbGpPWpGaD
Hydrocodone—OPRD1—Peptide GPCRs—CCR6—Crohn's disease	0.00592	0.0183	CbGpPWpGaD
Hydrocodone—Back pain—Mesalazine—Crohn's disease	0.00585	0.00937	CcSEcCtD
Hydrocodone—Naloxone—ALB—Crohn's disease	0.00584	0.111	CrCbGaD
Hydrocodone—Muscle spasms—Mesalazine—Crohn's disease	0.00582	0.00932	CcSEcCtD
Hydrocodone—Vomiting—Mercaptopurine—Crohn's disease	0.00578	0.00926	CcSEcCtD
Hydrocodone—Rash—Mercaptopurine—Crohn's disease	0.00573	0.00919	CcSEcCtD
Hydrocodone—Dermatitis—Mercaptopurine—Crohn's disease	0.00573	0.00918	CcSEcCtD
Hydrocodone—Tremor—Mesalazine—Crohn's disease	0.00567	0.00908	CcSEcCtD
Hydrocodone—Arthralgia—Azathioprine—Crohn's disease	0.00565	0.00906	CcSEcCtD
Hydrocodone—Myalgia—Azathioprine—Crohn's disease	0.00565	0.00906	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00561	0.00899	CcSEcCtD
Hydrocodone—OPRK1—Peptide ligand-binding receptors—ACKR2—Crohn's disease	0.00561	0.0174	CbGpPWpGaD
Hydrocodone—Lethargy—Prednisone—Crohn's disease	0.00542	0.00869	CcSEcCtD
Hydrocodone—Nausea—Mercaptopurine—Crohn's disease	0.0054	0.00866	CcSEcCtD
Hydrocodone—OPRK1—Peptide ligand-binding receptors—MLN—Crohn's disease	0.00532	0.0165	CbGpPWpGaD
Hydrocodone—Osteoarthritis—Prednisone—Crohn's disease	0.00531	0.00851	CcSEcCtD
Hydrocodone—Thrombocytopenia—Azathioprine—Crohn's disease	0.00531	0.0085	CcSEcCtD
Hydrocodone—Cough—Mesalazine—Crohn's disease	0.00528	0.00846	CcSEcCtD
Hydrocodone—Skin disorder—Azathioprine—Crohn's disease	0.00526	0.00843	CcSEcCtD
Hydrocodone—Affect lability—Prednisone—Crohn's disease	0.00523	0.00838	CcSEcCtD
Hydrocodone—OPRK1—Peptide GPCRs—CCR6—Crohn's disease	0.00519	0.0161	CbGpPWpGaD
Hydrocodone—Arthralgia—Mesalazine—Crohn's disease	0.00515	0.00825	CcSEcCtD
Hydrocodone—Myalgia—Mesalazine—Crohn's disease	0.00515	0.00825	CcSEcCtD
Hydrocodone—Anxiety—Mesalazine—Crohn's disease	0.00513	0.00822	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00511	0.00819	CcSEcCtD
Hydrocodone—Hypotension—Azathioprine—Crohn's disease	0.00506	0.00811	CcSEcCtD
Hydrocodone—Dry mouth—Mesalazine—Crohn's disease	0.00504	0.00807	CcSEcCtD
Hydrocodone—Mood swings—Prednisone—Crohn's disease	0.00503	0.00806	CcSEcCtD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.00501	0.0155	CbGpPWpGaD
Hydrocodone—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00494	0.00791	CcSEcCtD
Hydrocodone—Nervous system disorder—Mesalazine—Crohn's disease	0.00484	0.00776	CcSEcCtD
Hydrocodone—Hypokalaemia—Prednisone—Crohn's disease	0.00484	0.00775	CcSEcCtD
Hydrocodone—Thrombocytopenia—Mesalazine—Crohn's disease	0.00483	0.00774	CcSEcCtD
Hydrocodone—Skin disorder—Mesalazine—Crohn's disease	0.00479	0.00768	CcSEcCtD
Hydrocodone—Hyperhidrosis—Mesalazine—Crohn's disease	0.00477	0.00765	CcSEcCtD
Hydrocodone—OPRM1—Peptide ligand-binding receptors—ACKR2—Crohn's disease	0.00474	0.0147	CbGpPWpGaD
Hydrocodone—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00468	0.0075	CcSEcCtD
Hydrocodone—Hypotension—Mesalazine—Crohn's disease	0.00461	0.00739	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.0045	0.00721	CcSEcCtD
Hydrocodone—OPRM1—Peptide ligand-binding receptors—MLN—Crohn's disease	0.0045	0.0139	CbGpPWpGaD
Hydrocodone—Insomnia—Mesalazine—Crohn's disease	0.00446	0.00715	CcSEcCtD
Hydrocodone—Paraesthesia—Mesalazine—Crohn's disease	0.00443	0.0071	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00443	0.0071	CcSEcCtD
Hydrocodone—Dyspnoea—Mesalazine—Crohn's disease	0.0044	0.00705	CcSEcCtD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.00439	0.0136	CbGpPWpGaD
Hydrocodone—OPRM1—Peptide GPCRs—CCR6—Crohn's disease	0.00439	0.0136	CbGpPWpGaD
Hydrocodone—Somnolence—Mesalazine—Crohn's disease	0.00439	0.00703	CcSEcCtD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00429	0.0133	CbGpPWpGaD
Hydrocodone—Body temperature increased—Azathioprine—Crohn's disease	0.00428	0.00686	CcSEcCtD
Hydrocodone—Abdominal pain—Azathioprine—Crohn's disease	0.00428	0.00686	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00426	0.00683	CcSEcCtD
Hydrocodone—Fatigue—Mesalazine—Crohn's disease	0.00426	0.00682	CcSEcCtD
Hydrocodone—Constipation—Mesalazine—Crohn's disease	0.00422	0.00676	CcSEcCtD
Hydrocodone—OPRD1—Peptide ligand-binding receptors—CCR9—Crohn's disease	0.00421	0.013	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00407	0.0126	CbGpPWpGaD
Hydrocodone—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00404	0.00647	CcSEcCtD
Hydrocodone—Hypersensitivity—Azathioprine—Crohn's disease	0.00399	0.0064	CcSEcCtD
Hydrocodone—Body temperature increased—Mesalazine—Crohn's disease	0.0039	0.00625	CcSEcCtD
Hydrocodone—Abdominal pain—Mesalazine—Crohn's disease	0.0039	0.00625	CcSEcCtD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00376	0.0116	CbGpPWpGaD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.00371	0.0115	CbGpPWpGaD
Hydrocodone—OPRK1—Peptide ligand-binding receptors—CCR9—Crohn's disease	0.00369	0.0114	CbGpPWpGaD
Hydrocodone—Hypersensitivity—Mesalazine—Crohn's disease	0.00364	0.00583	CcSEcCtD
Hydrocodone—Connective tissue disorder—Prednisone—Crohn's disease	0.00361	0.00579	CcSEcCtD
Hydrocodone—Dizziness—Azathioprine—Crohn's disease	0.00358	0.00574	CcSEcCtD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00357	0.011	CbGpPWpGaD
Hydrocodone—OPRD1—G alpha (i) signalling events—CCR9—Crohn's disease	0.00355	0.011	CbGpPWpGaD
Hydrocodone—Asthenia—Mesalazine—Crohn's disease	0.00354	0.00567	CcSEcCtD
Hydrocodone—Pruritus—Mesalazine—Crohn's disease	0.00349	0.0056	CcSEcCtD
Hydrocodone—Vomiting—Azathioprine—Crohn's disease	0.00345	0.00552	CcSEcCtD
Hydrocodone—Rash—Azathioprine—Crohn's disease	0.00342	0.00547	CcSEcCtD
Hydrocodone—Dermatitis—Azathioprine—Crohn's disease	0.00341	0.00547	CcSEcCtD
Hydrocodone—Headache—Azathioprine—Crohn's disease	0.00339	0.00544	CcSEcCtD
Hydrocodone—Angiopathy—Prednisone—Crohn's disease	0.00334	0.00534	CcSEcCtD
Hydrocodone—OPRM1—IL4-mediated signaling events—SOCS1—Crohn's disease	0.00332	0.0103	CbGpPWpGaD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00329	0.0102	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—ACKR2—Crohn's disease	0.00327	0.0101	CbGpPWpGaD
Hydrocodone—Dizziness—Mesalazine—Crohn's disease	0.00326	0.00523	CcSEcCtD
Hydrocodone—OPRM1—TCR Signaling Pathway—IL17A—Crohn's disease	0.00325	0.0101	CbGpPWpGaD
Hydrocodone—Mental disorder—Prednisone—Crohn's disease	0.00322	0.00516	CcSEcCtD
Hydrocodone—Nausea—Azathioprine—Crohn's disease	0.00322	0.00516	CcSEcCtD
Hydrocodone—Malnutrition—Prednisone—Crohn's disease	0.0032	0.00513	CcSEcCtD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00318	0.00984	CbGpPWpGaD
Hydrocodone—Vomiting—Mesalazine—Crohn's disease	0.00314	0.00503	CcSEcCtD
Hydrocodone—OPRM1—Peptide ligand-binding receptors—CCR9—Crohn's disease	0.00312	0.00964	CbGpPWpGaD
Hydrocodone—Rash—Mesalazine—Crohn's disease	0.00311	0.00499	CcSEcCtD
Hydrocodone—OPRK1—G alpha (i) signalling events—CCR9—Crohn's disease	0.00311	0.00963	CbGpPWpGaD
Hydrocodone—Dermatitis—Mesalazine—Crohn's disease	0.00311	0.00498	CcSEcCtD
Hydrocodone—OPRD1—GPCR ligand binding—MLN—Crohn's disease	0.0031	0.00959	CbGpPWpGaD
Hydrocodone—Headache—Mesalazine—Crohn's disease	0.00309	0.00495	CcSEcCtD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00306	0.00947	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00302	0.00933	CbGpPWpGaD
Hydrocodone—OPRM1—IL4-mediated signaling events—IL10—Crohn's disease	0.00298	0.00922	CbGpPWpGaD
Hydrocodone—Nausea—Mesalazine—Crohn's disease	0.00293	0.0047	CcSEcCtD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00289	0.00893	CbGpPWpGaD
Hydrocodone—OPRM1—TCR Signaling Pathway—RIPK2—Crohn's disease	0.00289	0.00893	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—ACKR2—Crohn's disease	0.00287	0.00887	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00282	0.00873	CbGpPWpGaD
Hydrocodone—OPRD1—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.00279	0.00862	CbGpPWpGaD
Hydrocodone—Convulsion—Prednisone—Crohn's disease	0.00277	0.00444	CcSEcCtD
Hydrocodone—Myalgia—Prednisone—Crohn's disease	0.00272	0.00436	CcSEcCtD
Hydrocodone—Arthralgia—Prednisone—Crohn's disease	0.00272	0.00436	CcSEcCtD
Hydrocodone—OPRK1—GPCR ligand binding—MLN—Crohn's disease	0.00272	0.00841	CbGpPWpGaD
Hydrocodone—Anxiety—Prednisone—Crohn's disease	0.00271	0.00435	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00271	0.00433	CcSEcCtD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00268	0.0083	CbGpPWpGaD
Hydrocodone—OPRM1—G alpha (i) signalling events—CCR9—Crohn's disease	0.00263	0.00814	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00262	0.00811	CbGpPWpGaD
Hydrocodone—Nervous system disorder—Prednisone—Crohn's disease	0.00256	0.0041	CcSEcCtD
Hydrocodone—Skin disorder—Prednisone—Crohn's disease	0.00254	0.00406	CcSEcCtD
Hydrocodone—Hyperhidrosis—Prednisone—Crohn's disease	0.00252	0.00405	CcSEcCtD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00247	0.00765	CbGpPWpGaD
Hydrocodone—OPRK1—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.00244	0.00756	CbGpPWpGaD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00244	0.00755	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—ACKR2—Crohn's disease	0.00242	0.0075	CbGpPWpGaD
Hydrocodone—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.00238	0.00381	CcSEcCtD
Hydrocodone—Insomnia—Prednisone—Crohn's disease	0.00236	0.00378	CcSEcCtD
Hydrocodone—OPRD1—G alpha (i) signalling events—CCR6—Crohn's disease	0.00235	0.00727	CbGpPWpGaD
Hydrocodone—Paraesthesia—Prednisone—Crohn's disease	0.00235	0.00376	CcSEcCtD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.0023	0.00712	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—MLN—Crohn's disease	0.0023	0.00711	CbGpPWpGaD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00227	0.00702	CbGpPWpGaD
Hydrocodone—Fatigue—Prednisone—Crohn's disease	0.00225	0.00361	CcSEcCtD
Hydrocodone—Constipation—Prednisone—Crohn's disease	0.00223	0.00358	CcSEcCtD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00218	0.00675	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—CCR9—Crohn's disease	0.00215	0.00665	CbGpPWpGaD
Hydrocodone—Gastrointestinal pain—Prednisone—Crohn's disease	0.00214	0.00342	CcSEcCtD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00209	0.00647	CbGpPWpGaD
Hydrocodone—OPRM1—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.00206	0.00639	CbGpPWpGaD
Hydrocodone—Abdominal pain—Prednisone—Crohn's disease	0.00206	0.00331	CcSEcCtD
Hydrocodone—Body temperature increased—Prednisone—Crohn's disease	0.00206	0.00331	CcSEcCtD
Hydrocodone—OPRK1—G alpha (i) signalling events—CCR6—Crohn's disease	0.00206	0.00638	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—GPR65—Crohn's disease	0.002	0.00618	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00194	0.00601	CbGpPWpGaD
Hydrocodone—Hypersensitivity—Prednisone—Crohn's disease	0.00192	0.00308	CcSEcCtD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00192	0.00594	CbGpPWpGaD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00191	0.00592	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—CCR9—Crohn's disease	0.00188	0.00583	CbGpPWpGaD
Hydrocodone—Asthenia—Prednisone—Crohn's disease	0.00187	0.003	CcSEcCtD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00187	0.00578	CbGpPWpGaD
Hydrocodone—Pruritus—Prednisone—Crohn's disease	0.00185	0.00296	CcSEcCtD
Hydrocodone—OPRM1—IL4-mediated signaling events—JAK2—Crohn's disease	0.00179	0.00552	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—MLN—Crohn's disease	0.00175	0.00542	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—GPR65—Crohn's disease	0.00175	0.00542	CbGpPWpGaD
Hydrocodone—OPRM1—G alpha (i) signalling events—CCR6—Crohn's disease	0.00174	0.00539	CbGpPWpGaD
Hydrocodone—Dizziness—Prednisone—Crohn's disease	0.00173	0.00277	CcSEcCtD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00168	0.00521	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—ACKR2—Crohn's disease	0.00168	0.00519	CbGpPWpGaD
Hydrocodone—Vomiting—Prednisone—Crohn's disease	0.00166	0.00266	CcSEcCtD
Hydrocodone—Rash—Prednisone—Crohn's disease	0.00165	0.00264	CcSEcCtD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00165	0.00509	CbGpPWpGaD
Hydrocodone—Dermatitis—Prednisone—Crohn's disease	0.00165	0.00264	CcSEcCtD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00164	0.00507	CbGpPWpGaD
Hydrocodone—Headache—Prednisone—Crohn's disease	0.00164	0.00262	CcSEcCtD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00162	0.005	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—CCR9—Crohn's disease	0.00159	0.00493	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—MLN—Crohn's disease	0.00159	0.00492	CbGpPWpGaD
Hydrocodone—Nausea—Prednisone—Crohn's disease	0.00155	0.00249	CcSEcCtD
Hydrocodone—OPRK1—GPCR downstream signaling—MLN—Crohn's disease	0.00154	0.00475	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—GPR65—Crohn's disease	0.00148	0.00458	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—ACKR2—Crohn's disease	0.00147	0.00455	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00144	0.00446	CbGpPWpGaD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00142	0.0044	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—CCR6—Crohn's disease	0.00142	0.0044	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—MLN—Crohn's disease	0.00139	0.00431	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00138	0.00428	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—MLN—Crohn's disease	0.0013	0.00402	CbGpPWpGaD
Hydrocodone—OPRM1—TCR Signaling Pathway—CD4—Crohn's disease	0.00126	0.00389	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—PTGER4—Crohn's disease	0.00125	0.00388	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—CCR6—Crohn's disease	0.00125	0.00386	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—ACKR2—Crohn's disease	0.00124	0.00385	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00122	0.00377	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—CCR9—Crohn's disease	0.00121	0.00376	CbGpPWpGaD
Hydrocodone—CYP2D6—Metapathway biotransformation—GPX4—Crohn's disease	0.0012	0.00373	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—MLN—Crohn's disease	0.00118	0.00365	CbGpPWpGaD
Hydrocodone—OPRM1—TCR Signaling Pathway—IL1B—Crohn's disease	0.00116	0.00359	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—GPR65—Crohn's disease	0.00113	0.00349	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CCR9—Crohn's disease	0.0011	0.00341	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—PTGER4—Crohn's disease	0.0011	0.0034	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—CCR9—Crohn's disease	0.00106	0.00329	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—CCR6—Crohn's disease	0.00105	0.00326	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—GPR65—Crohn's disease	0.00102	0.00317	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—ACKR2—Crohn's disease	0.000991	0.00307	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—GPR65—Crohn's disease	0.00099	0.00306	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CCR9—Crohn's disease	0.000967	0.00299	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MLN—Crohn's disease	0.00094	0.00291	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—PTGER4—Crohn's disease	0.000929	0.00287	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—CCR9—Crohn's disease	0.0009	0.00278	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—GPR65—Crohn's disease	0.000899	0.00278	CbGpPWpGaD
Hydrocodone—OPRD1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.000898	0.00278	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ACKR2—Crohn's disease	0.000869	0.00269	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TAGAP—Crohn's disease	0.000859	0.00266	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—GPR65—Crohn's disease	0.000836	0.00259	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MLN—Crohn's disease	0.000824	0.00255	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CCR9—Crohn's disease	0.000817	0.00253	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—CCR6—Crohn's disease	0.000804	0.00249	CbGpPWpGaD
Hydrocodone—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	0.000787	0.00244	CbGpPWpGaD
Hydrocodone—OPRK1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.000787	0.00244	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—GPR65—Crohn's disease	0.00076	0.00235	CbGpPWpGaD
Hydrocodone—OPRD1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000757	0.00234	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TAGAP—Crohn's disease	0.000754	0.00233	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—RSPO3—Crohn's disease	0.000751	0.00232	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ACKR2—Crohn's disease	0.000735	0.00227	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CCR6—Crohn's disease	0.00073	0.00226	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—SEL1L—Crohn's disease	0.000712	0.0022	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000708	0.00219	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—CCR6—Crohn's disease	0.000705	0.00218	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MLN—Crohn's disease	0.000696	0.00215	CbGpPWpGaD
Hydrocodone—OPRM1—TCR Signaling Pathway—IL6—Crohn's disease	0.000679	0.0021	CbGpPWpGaD
Hydrocodone—OPRM1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.000665	0.00206	CbGpPWpGaD
Hydrocodone—OPRK1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000664	0.00205	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—RSPO3—Crohn's disease	0.000659	0.00204	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CCR9—Crohn's disease	0.000651	0.00201	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—PTGER4—Crohn's disease	0.000643	0.00199	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CCR6—Crohn's disease	0.00064	0.00198	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TAGAP—Crohn's disease	0.000637	0.00197	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—SEL1L—Crohn's disease	0.000624	0.00193	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000621	0.00192	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—GPR65—Crohn's disease	0.000605	0.00187	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—IL3—Crohn's disease	0.000603	0.00187	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000602	0.00186	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—CCR6—Crohn's disease	0.000596	0.00184	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000583	0.0018	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCR9—Crohn's disease	0.000571	0.00177	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—PTGER4—Crohn's disease	0.000564	0.00174	CbGpPWpGaD
Hydrocodone—OPRM1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000561	0.00174	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—RSPO3—Crohn's disease	0.000557	0.00172	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—IL3—Crohn's disease	0.000548	0.00169	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CCR6—Crohn's disease	0.000541	0.00167	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—GPR65—Crohn's disease	0.000531	0.00164	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—RASGRP1—Crohn's disease	0.00053	0.00164	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—IL3—Crohn's disease	0.000529	0.00164	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000528	0.00163	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—SEL1L—Crohn's disease	0.000528	0.00163	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000525	0.00162	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000511	0.00158	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCR9—Crohn's disease	0.000483	0.00149	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—IL3—Crohn's disease	0.00048	0.00149	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—PTGER4—Crohn's disease	0.000476	0.00147	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000464	0.00144	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—CXCL8—Crohn's disease	0.000459	0.00142	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—GPR65—Crohn's disease	0.000449	0.00139	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—IL3—Crohn's disease	0.000447	0.00138	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000446	0.00138	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000432	0.00134	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CCR6—Crohn's disease	0.000431	0.00133	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000422	0.00131	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—IL3—Crohn's disease	0.000406	0.00126	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—CXCL8—Crohn's disease	0.000402	0.00124	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000393	0.00121	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—RBX1—Crohn's disease	0.00039	0.00121	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—IL2RA—Crohn's disease	0.000384	0.00119	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PTGER4—Crohn's disease	0.00038	0.00118	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCR6—Crohn's disease	0.000378	0.00117	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—IL2RA—Crohn's disease	0.00037	0.00115	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—RBX1—Crohn's disease	0.000342	0.00106	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—UBE2D1—Crohn's disease	0.000342	0.00106	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—CXCL8—Crohn's disease	0.00034	0.00105	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	0.000337	0.00104	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—IL2RA—Crohn's disease	0.000336	0.00104	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PTGER4—Crohn's disease	0.000333	0.00103	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—RIPK2—Crohn's disease	0.000332	0.00103	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IL3—Crohn's disease	0.000324	0.001	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCR6—Crohn's disease	0.00032	0.000989	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000313	0.000969	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—RASGRP1—Crohn's disease	0.000313	0.000968	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—UBE2D1—Crohn's disease	0.0003	0.000928	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—RIPK2—Crohn's disease	0.000291	0.0009	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—RBX1—Crohn's disease	0.000289	0.000895	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—MTMR3—Crohn's disease	0.000286	0.000886	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—IL2RA—Crohn's disease	0.000284	0.00088	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—JAK2—Crohn's disease	0.000284	0.000878	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL3—Crohn's disease	0.000284	0.000878	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—SOCS1—Crohn's disease	0.000283	0.000877	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PTGER4—Crohn's disease	0.000281	0.000871	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—RASGRP1—Crohn's disease	0.000274	0.000849	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—TYK2—Crohn's disease	0.00027	0.000836	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000259	0.000802	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—JAK2—Crohn's disease	0.000258	0.000798	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—UBE2D1—Crohn's disease	0.000254	0.000784	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—JAK2—Crohn's disease	0.000249	0.00077	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—SOCS1—Crohn's disease	0.000249	0.000769	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—RIPK2—Crohn's disease	0.000246	0.000761	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—SMAD3—Crohn's disease	0.000245	0.000757	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL3—Crohn's disease	0.00024	0.000742	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—TYK2—Crohn's disease	0.000237	0.000733	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CXCL8—Crohn's disease	0.000235	0.000728	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—RASGRP1—Crohn's disease	0.000232	0.000717	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000227	0.000703	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IL2RA—Crohn's disease	0.000227	0.000701	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—JAK2—Crohn's disease	0.000226	0.0007	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—FADS1—Crohn's disease	0.000223	0.00069	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	0.00022	0.000681	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—SMAD3—Crohn's disease	0.000215	0.000664	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—JAK2—Crohn's disease	0.00021	0.000651	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—SOCS1—Crohn's disease	0.00021	0.00065	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GPX4—Crohn's disease	0.000209	0.000646	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CXCL8—Crohn's disease	0.000206	0.000638	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GCKR—Crohn's disease	0.000202	0.000624	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—TYK2—Crohn's disease	0.0002	0.00062	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL2RA—Crohn's disease	0.000199	0.000615	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000192	0.000594	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—JAK2—Crohn's disease	0.000191	0.000591	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—MTMR3—Crohn's disease	0.000187	0.000579	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—SMAD3—Crohn's disease	0.000181	0.000561	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CXCL8—Crohn's disease	0.000174	0.00054	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL2RA—Crohn's disease	0.000168	0.00052	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TYK2—Crohn's disease	0.00016	0.000494	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—JAK2—Crohn's disease	0.000152	0.000471	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—FADS1—Crohn's disease	0.000146	0.000451	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TYK2—Crohn's disease	0.00014	0.000433	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CXCL8—Crohn's disease	0.000139	0.00043	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GPX4—Crohn's disease	0.000137	0.000422	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—JAK2—Crohn's disease	0.000134	0.000413	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—IL6—Crohn's disease	0.000132	0.000409	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GCKR—Crohn's disease	0.000132	0.000408	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CXCL8—Crohn's disease	0.000122	0.000377	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TYK2—Crohn's disease	0.000118	0.000366	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—IL6—Crohn's disease	0.000116	0.000359	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—JAK2—Crohn's disease	0.000113	0.000349	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—STAT3—Crohn's disease	0.000112	0.000346	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CXCL8—Crohn's disease	0.000103	0.000319	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—STAT3—Crohn's disease	9.8e-05	0.000303	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—IL6—Crohn's disease	9.8e-05	0.000303	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—STAT3—Crohn's disease	8.29e-05	0.000256	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IL6—Crohn's disease	7.81e-05	0.000242	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL6—Crohn's disease	6.85e-05	0.000212	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ALB—Crohn's disease	6.42e-05	0.000199	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL6—Crohn's disease	5.79e-05	0.000179	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PTGS2—Crohn's disease	5.62e-05	0.000174	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ALB—Crohn's disease	4.2e-05	0.00013	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PTGS2—Crohn's disease	3.67e-05	0.000114	CbGpPWpGaD
